Jeffrey Courtney
Directeur/Membre du Conseil chez Xceed Molecular Corp.
Profil
Jeffrey T.
Courtney is currently a Director at ActivBiotics, Inc., Xceed Molecular Corp., XLV Diagnostics, Inc., Turnstone Biologics, Inc., and Chief Commercial Officer at Ontario Institute for Cancer Research since 2012.
He previously worked as a Product Director at Johnson & Johnson, Director at Targanta Therapeutics Corp., Kadmus Pharmaceuticals, Inc., VisualSonics, Inc., Axela, Inc., Interface Biologics, Inc., Managing Director at Verde Ventures, Director at Centre For Imaging Technology Commercialization, General Partner at VenGrowth Capital Partners, Inc., Partner at CDP Capital Private Equity, and Executive Vice President-Sales & Marketing at Pharmascience, Inc. He completed his undergraduate degree at the University of Guelph.
Postes actifs de Jeffrey Courtney
| Sociétés | Poste | Début |
|---|---|---|
Xceed Molecular Corp.
 Xceed Molecular Corp. Medical SpecialtiesHealth Technology Xceed Molecular Corporation is a molecular diagnostic company dedicated to commercializing a platform for automated gene expression analysis and developing proprietary clinical research assays and custom arrays. They develop tools and content aimed at accelerating the current market trend towards 'translational medicine', and bridging the gap from gene signature validation to clinical diagnostics. The Ziplex Automated Workstation is the first integrated and fully automated hybridization system for multiplex gene expression signatures. Their integrated solution - the Ziplex System - features this innovative instrument platform and focused-content TipChip arrays and reagents to perform highly multiplexed molecular assays with superior accuracy, reproducibility, speed and scalability. The Ziplex System is designed to provide the ease-of-use in assay automation and analytics that is required to successfully translate gene expression analysis from research use into routine practice. Xceed complements the Ziplex platform by offering Gene Expression Services and Assay Development Services. | Directeur/Membre du Conseil | - |
ActivBiotics, Inc.
 ActivBiotics, Inc. BiotechnologyHealth Technology ActivBiotics, Inc. discovers and develops pharmaceutical drugs. It provides discovery, development, and commercialization of therapies for the treatment of vascular disease, inflammation, and other high-value chronic and infectious diseases. The company was founded in 1996 and is headquartered in Lexington, MA. | Directeur/Membre du Conseil | - |
Ontario Institute for Cancer Research
 Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | 12/11/2012 |
Turnstone Biologics, Inc.
 Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Directeur/Membre du Conseil | - |
XLV Diagnostics, Inc.
 XLV Diagnostics, Inc. Medical SpecialtiesHealth Technology XLV Diagnostics, Inc. operates as a medical imaging equipment company that develops, manufactures, and commercializes X-ray detectors for digital radiology machines used in early cancer detection and treatment applications. The firm also offers digital mammography machines. The company was founded in June 2011 and is headquartered in Thunder Bay, Canada. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jeffrey Courtney
| Sociétés | Poste | Fin |
|---|---|---|
Targanta Therapeutics Corp.
 Targanta Therapeutics Corp. BiotechnologyHealth Technology Targanta Therapeutics Corp. discovers and develops novel antibacterial pro drugs. The company was founded in 1997 and is headquartered in Parsippany, NJ. | Directeur/Membre du Conseil | 26/02/2009 |
CDP Capital Private Equity
 CDP Capital Private Equity Investment ManagersFinance CDP Capital Private Equity (CDPQ) is a private equity subsidiary of The Caisse de dépôt et placement du Québec founded in 1995. The firm is headquartered in Montréal with additional office in London. | Private Equity Investor | 31/12/2001 |
Centre For Imaging Technology Commercialization
 Centre For Imaging Technology Commercialization Packaged SoftwareTechnology Services Centre For Imaging Technology Commercialization medical technology manufacturer. The company is headquartered in London, Canada. | Directeur/Membre du Conseil | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
| ░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Jeffrey Courtney
| University of Guelph | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Entreprise privées | 15 |
|---|---|
ActivBiotics, Inc.
ActivBiotics, Inc. BiotechnologyHealth Technology ActivBiotics, Inc. discovers and develops pharmaceutical drugs. It provides discovery, development, and commercialization of therapies for the treatment of vascular disease, inflammation, and other high-value chronic and infectious diseases. The company was founded in 1996 and is headquartered in Lexington, MA. | Health Technology |
Xceed Molecular Corp.
Xceed Molecular Corp. Medical SpecialtiesHealth Technology Xceed Molecular Corporation is a molecular diagnostic company dedicated to commercializing a platform for automated gene expression analysis and developing proprietary clinical research assays and custom arrays. They develop tools and content aimed at accelerating the current market trend towards 'translational medicine', and bridging the gap from gene signature validation to clinical diagnostics. The Ziplex Automated Workstation is the first integrated and fully automated hybridization system for multiplex gene expression signatures. Their integrated solution - the Ziplex System - features this innovative instrument platform and focused-content TipChip arrays and reagents to perform highly multiplexed molecular assays with superior accuracy, reproducibility, speed and scalability. The Ziplex System is designed to provide the ease-of-use in assay automation and analytics that is required to successfully translate gene expression analysis from research use into routine practice. Xceed complements the Ziplex platform by offering Gene Expression Services and Assay Development Services. | Health Technology |
Targanta Therapeutics Corp.
Targanta Therapeutics Corp. BiotechnologyHealth Technology Targanta Therapeutics Corp. discovers and develops novel antibacterial pro drugs. The company was founded in 1997 and is headquartered in Parsippany, NJ. | Health Technology |
VenGrowth Capital Partners, Inc.
 VenGrowth Capital Partners, Inc. Investment ManagersFinance Founded in 1982, VenGrowth Capital Partners, Inc. is a private equity and venture capital firm located in Toronto, Ontario. The firm is a subsidiary of Covington Capital Corp. They manage retail and institutional assets. | Finance |
CDP Capital Private Equity
CDP Capital Private Equity Investment ManagersFinance CDP Capital Private Equity (CDPQ) is a private equity subsidiary of The Caisse de dépôt et placement du Québec founded in 1995. The firm is headquartered in Montréal with additional office in London. | Finance |
Kadmus Pharmaceuticals, Inc.
 Kadmus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kadmus Pharmaceuticals, Inc. manufactures and sells biopharmaceutical products. It develops and commercializes proprietary molecules targeting critical pathways contributing to pain, disorders of the nervous system, and other unmet medical needs. The firm also performs formulation, pre-clinical development and also oversees the manufacturing, preclinical toxicology, and clinical development of candidate drugs via a key vendor network. Kadmus Pharmaceuticals was founded in 1998 and is headquartered in Irvine, CA. | Health Technology |
VisualSonics, Inc.
 VisualSonics, Inc. Medical SpecialtiesHealth Technology VisualSonics, Inc. developed vivo imaging systems for non-invasive small animal research. The company was founded by F. Stuart Foster in 1999 and headquartered in Toronto, Canada. | Health Technology |
Axela, Inc.
 Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada. | Health Technology |
Interface Biologics, Inc.
 Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | Technology Services |
Pharmascience, Inc.
 Pharmascience, Inc. Pharmaceuticals: MajorHealth Technology Pharmascience, Inc. manufactures and distributes generic and drug products. It offers liquids, tablets, capsules, suppositories, powders, and ophthalmic. The company was founded by Morris Goodman and Ted S. Wise in 1983 and is headquartered in Montr?al, Canada. | Health Technology |
Verde Ventures
 Verde Ventures Investment ManagersFinance Verde Ventures (Verde) is a venture capital subsidiary of Conservation International Foundation founded in 1998. The firm is headquartered in Arlington, Virginia. | Finance |
Ontario Institute for Cancer Research
Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Health Services |
XLV Diagnostics, Inc.
XLV Diagnostics, Inc. Medical SpecialtiesHealth Technology XLV Diagnostics, Inc. operates as a medical imaging equipment company that develops, manufactures, and commercializes X-ray detectors for digital radiology machines used in early cancer detection and treatment applications. The firm also offers digital mammography machines. The company was founded in June 2011 and is headquartered in Thunder Bay, Canada. | Health Technology |
Centre For Imaging Technology Commercialization
Centre For Imaging Technology Commercialization Packaged SoftwareTechnology Services Centre For Imaging Technology Commercialization medical technology manufacturer. The company is headquartered in London, Canada. | Technology Services |
Turnstone Biologics, Inc.
Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Health Technology |
